Galderma S.A. - Strategic SWOT Analysis Review

Date: January 27, 2015
Pages: 35
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G48F7D14F59EN
Leaflet:

Download PDF Leaflet

Galderma S.A. - Strategic SWOT Analysis Review
Galderma S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.

    Highlights

    Galderma S.A. (Galderma) is a pharmaceutical company. It develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. The company products include arcolan, azzalure, benzac, calmurid, capex, cetaphil, clindagel, clobex, desowen, differin, dysport, efficort, eryacne, macrolane, metrogel, nutracort, nutraderm, oracea, restylane, tetralysal, silkis, tri-luma, and vectical.

    Galderma S.A. Key Recent Developments

    Dec 11, 2014 Nestle Skin Health to Open Global Network of Innovation Hubs to Advance Next Generation of Skin Health
    Oct 09, 2014 Skinpact Programme Launched Today With New Global Awards Initiative To Support The Dermatology Community
    Oct 09, 2014 SKINPACT Programme Launched with New Global Awards Initiative to Support the Dermatology Community
    Oct 06, 2014 Galderma Initiates U.S. Study of Novel Muscle Relaxant for Aesthetic Dermatology and Cosmetic Surgery
    Jul 10, 2014 Galderma Finalizes Major Expansion in Aesthetic and Corrective Dermatology in the U.S. and Canada

    Reasons to Buy
    • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
    • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
    • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
    • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
    Note: Some sections may be missing if data is unavailable for the company.
  • SECTION 1 - ABOUT THE COMPANY

    Galderma S.A. - Key Facts
    Galderma S.A. - Key Employees
    Galderma S.A. - Major Products and Services
    Galderma S.A. - Pharmaceutical Pipeline Products Data
    Galderma S.A., Pipeline Products by Therapy Area
    Galderma S.A., Pipeline Products by Development Phase
    Galderma S.A. - History
    Galderma S.A. - Company Statement
    Galderma S.A. - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    Galderma S.A. - Business Description
    Galderma S.A. - SWOT Analysis
    SWOT Analysis - Overview
    Galderma S.A. - Strengths
    Strength - Strong Market Presence
    Strength - Robust Manufacturing Capabilities
    Strength - Strong In-house Research Capabilities
    Galderma S.A. - Weaknesses
    Weakness - Private Ownership
    Weakness - Litigation Claims
    Galderma S.A. - Opportunities
    Opportunity - Orphan Drug Designation
    Opportunity - Products in Pipeline
    Opportunity - Strategic Acquisitions and Collaborations
    Opportunity - New Product Launches
    Galderma S.A. - Threats
    Threat - Increasing Counterfeit Products
    Threat - Stringent Government Regulations
    Threat - Failure of New Product in Clinical Trials
    Galderma S.A. - Key Competitors

    SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Galderma S.A., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
    Galderma S.A., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
    Galderma S.A., Recent Deals Summary

    SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

    Dec 11, 2014: Nestle Skin Health to Open Global Network of Innovation Hubs to Advance Next Generation of Skin Health
    Oct 09, 2014: SKINPACT Programme Launched with New Global Awards Initiative to Support the Dermatology Community
    Oct 09, 2014: Skinpact Programme Launched Today With New Global Awards Initiative To Support The Dermatology Community
    Oct 06, 2014: Galderma Initiates U.S. Study of Novel Muscle Relaxant for Aesthetic Dermatology and Cosmetic Surgery
    Jul 10, 2014: Galderma Finalizes Major Expansion in Aesthetic and Corrective Dermatology in the U.S. and Canada
    Jan 08, 2014: Galderma Announces CEO for North American Operations

    SECTION 5 – APPENDIX

    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Galderma S.A., Key Facts
    Galderma S.A., Key Employees
    Galderma S.A., Major Products and Services
    Galderma S.A., Number of Pipeline Products by Therapy Area
    Galderma S.A., Number of Pipeline Products by Development Stage
    Galderma S.A., Pipeline Products By Therapy Area and Development Phase
    Galderma S.A., History
    Galderma S.A., Other Locations
    Galderma S.A., Subsidiaries
    Galderma S.A., Key Competitors
    Galderma S.A., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
    Galderma S.A., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
    Galderma S.A., Recent Deals Summary

    LIST OF FIGURES

    Galderma S.A., Pipeline Products by Therapy Area
    Galderma S.A., Pipeline Products by Development Phase
    Galderma S.A., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
    Galderma S.A., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
    Skip to top


    Ask Your Question

    Galderma S.A. - Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: